Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-28T16:11:12.568Z Has data issue: false hasContentIssue false

Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study

Published online by Cambridge University Press:  09 March 2007

C. M. Williams*
Affiliation:
Hugh Sinclair Unit of Human Nutrition, Department of Food Science and Technology University of Reading, Reading RG6 6AP, UK
J. A. Francis-Knapper
Affiliation:
School of Biological Sciences University of Surrey, Guildford, GU2 5XH, UK
D. Webb
Affiliation:
School of Biological Sciences University of Surrey, Guildford, GU2 5XH, UK
C. A. Brookes
Affiliation:
School of Biological Sciences University of Surrey, Guildford, GU2 5XH, UK
A. Zampelas
Affiliation:
School of Biological Sciences University of Surrey, Guildford, GU2 5XH, UK
J. A. Tredger
Affiliation:
School of Biological Sciences University of Surrey, Guildford, GU2 5XH, UK
J. Wright
Affiliation:
School of Biological Sciences University of Surrey, Guildford, GU2 5XH, UK
G. Meijer
Affiliation:
Unilever Research Laboratory Vlaardingen, The Netherlands
P. C. Calder
Affiliation:
Department of Biochemistry University of Oxford, Oxford, OX1 3QU, UK
P. Yaqoob
Affiliation:
Department of Biochemistry University of Oxford, Oxford, OX1 3QU, UK
H. Roche
Affiliation:
Department of Medicine Trinity College, Dublin, Republic of Ireland
M. J. Gibney
Affiliation:
Department of Medicine Trinity College, Dublin, Republic of Ireland
*
*Corresponding author: Professor Christine Williams, fax +44 (0) 1189 310080, email C.M.Williams@reading.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In two separate studies, the cholesterol-lowering efficacy of a diet high in monounsaturated fatty acids (MUFA) was evaluated by means of a randomized crossover trial. In both studies subjects were randomized to receive either a high-MUFA diet or the control diet first, which they followed for a period of 8 weeks; following a washout period of 4–6 weeks they were transferred onto the opposing diet for a further period of 8 weeks. In one study subjects were healthy middle-aged men (n 30), and in the other they were young men (n 23) with a family history of CHD recruited from two centres (Guildford and Dublin). The two studies were conducted over the same time period using identical foods and study designs. Subjects consumed 38 % energy as fat, with 18 % energy as MUFA and 10 % as saturated fatty acids (MUFA diet), or 13 % energy as MUFA and 16 % as saturated fatty acids (control diet). The polyunsaturated fatty acid content of each diet was 7 %. The diets were achieved by providing subjects with manufactured foods such as spreads, ‘ready meals’, biscuits, puddings and breads, which, apart from their fatty acid compositions, were identical for both diets. Subjects were blind to which of the diets they were following on both arms of the study. Weight changes on the diets were less than 1 kg. In the groups combined (n 53) mean total and LDL-cholesterol levels were significantly lower at the end of the MUFA diet than the control diet by 0·29 (sd 0·61) mmol/l (P < 0·001) and 0·38 (sd 0·64) mmol/l (P < 0·0001) respectively. In middle-aged men these differences were due to a mean reduction in LDL-cholesterol of – 11 (sd 12) % on the MUFA diet with no change on the control diet (−1·1 (sd 10) %). In young men the differences were due to an increase in LDL-cholesterol concentration on the control diet of +6·2 (sd 13) % and a decrease on the MUFA diet of −7·8 (sd 20) %. Differences in the responses of middle-aged and young men to the two diets did not appear to be due to differences in their habitual baseline diets which were generally similar, but appeared to reflect the lower baseline cholesterol concentrations in the younger men. There was a moderately strong and statistically significant inverse correlation between the change in LDL-cholesterol concentration on each diet and the baseline fasting LDL-cholesterol concentration (r – 0·49; P < 0·0005). In conclusion, diets in which saturated fat is partially replaced by MUFA can achieve significant reductions in total and LDL-cholesterol concentrations, even when total fat and energy intakes are maintained. The dietary approach used to alter fatty acid intakes would be appropriate for achieving reductions in saturated fat intakes in whole populations.

Type
Research Article
Copyright
Copyright © The Nutrition Society 1999

References

Department of Health (1991) Dietary Values for Food Energy and Nutrients for the United Kingdom. Report on Health and Social Subjects no. 41. London: H. M. Stationery Office.Google Scholar
Department of Health (1994) Nutritional Aspects of Cardiovascular Disease. Report on Health and Social Subjects no. 46. London: H. M. Stationery Office.Google Scholar
Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifugation. Clinical Chemistry 18, 499502.CrossRefGoogle Scholar
Gregory, J, Foster, K, Tyler, H & Wiseman, M (1990) The Dietary and Nutritional Survey of British Adults. London: H. M. Stationery Office.Google Scholar
Keys, A, Anderson, JT & Grande, P (1957) Prediction of serum-cholesterol responses of man to changes in fats in the diet. Lancet ii, 959966.CrossRefGoogle Scholar
Law, MR, Wald, NJ & Thompson, SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. British Medical Journal 308, 367372.CrossRefGoogle ScholarPubMed
Ministry of Agriculture, Fisheries and Food (1992) Household Food Consumption and Expenditure. London: H. M. Stationery Office.Google Scholar
Pyörälä, K, De Backer, G & Graham, L (1994) Prevention of coronary heart disease in clinical practice, recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. European Heart Journal 15, 13001331.Google Scholar
Roche, HM, Zampelas, A, Knapper, JME, Webb, D, Brooks, C, Jackson, KG, Wright, JW, Gould, BJ, Kafatos, A, Gibney, MJ & Williams, CM (1998) The effect of chronic olive oil dietary intervention on acute postprandial triacylglycerol and factor VII metabolism. American Journal of Clinical Nutrition 68, 552560.CrossRefGoogle Scholar
Scandinavian Simvastatin Survival Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 13831389.Google Scholar
Shepherd, J, Stuart, MC, Ford, I, Isles, C, Lorimer, AR, Macfarlane, PW, McKillop, JH & Packard, CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine 333, 13011307.CrossRefGoogle ScholarPubMed
Yaqoob, P, Knapper, JA, Webb, DH, Williams, CM, Newsholme, EA & Calder, PC (1998) Effect of olive oil on immune function in middle aged men. American Journal of Clinical Nutrition 67, 129135.CrossRefGoogle ScholarPubMed
Yu, S, Derr, J, Etherton, TD & Kris-Etherton, PM (1995) Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. American Journal of Clinical Nutrition 61, 11291139.CrossRefGoogle ScholarPubMed